Alrusan Anas, Essa Suhaib Bani, Alhowary Ala A, Hani Diab Bani, Hazaymeh Mohammad Al, Alradaideh Mohammad, Alameri Halah, Younes Ahmad Bani, Al-Badarneh Noor, Alradaideh Saba
Department of Anesthesia and Pain Management, Faculty of Medicine, Jordan University of Science and Technology, Irbid 21110, Jordan .
Division of Orthopedics, Department of Special Surgery, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan.
Med Arch. 2025;79(3):205-210. doi: 10.5455/medarh.2025.79.205-210.
Pain-free and relief are one of the anesthesiologist's most important concerns during the operation. General aim is always to effectively control pain but while simultaneously reducing opioid requirements to reduce opioid related side effects and mortality. Patients undergoing orthopedic operations tend to have high pain scores and analgesic requirements.
In this study, we aim to investigate the effect of adding nefopam on reducing the postoperative pain scores and the need for opioids.
This double-blind placebo-controlled prospective study aims to determine the effectiveness of nefopam in relieving the pain resulting from the operation in addition to the pain resulting from tourniquet. The unlabeled drug solution was administered one at the beginning of surgery. A 10 mL solution containing nefopam 20 mg or placebo diluted with normal saline was infused over 20 min. 11-point visual analogue scale was utilized to assess the pain score.
Forty-nine participants enrolled in the study, 24 received nefopam. The mean age was 40.45 years. Participants received nefopam achieved better postoperative surgical site pain score, less intraoperative and postoperative opioids use. Nefopam utilization was the single independent factor affecting the postoperative pain score.
Compared with placebo, opioid requirement was decreased, the pain resulting from operation and tourniquet pain were decreased.
术中无痛及疼痛缓解是麻醉医生最为关注的问题之一。总体目标始终是有效控制疼痛,同时减少阿片类药物的用量,以降低阿片类药物相关的副作用和死亡率。接受骨科手术的患者往往疼痛评分较高且镇痛需求较大。
在本研究中,我们旨在探讨加用奈福泮对降低术后疼痛评分及阿片类药物需求的影响。
这项双盲、安慰剂对照的前瞻性研究旨在确定奈福泮除了缓解止血带所致疼痛外,在减轻手术所致疼痛方面的有效性。在手术开始时给予一种未标记的药物溶液。将含有20mg奈福泮或用生理盐水稀释的安慰剂的10mL溶液在20分钟内输注完毕。采用11点视觉模拟量表评估疼痛评分。
49名参与者纳入本研究,24名接受奈福泮治疗。平均年龄为40.45岁。接受奈福泮治疗的参与者术后手术部位疼痛评分更低,术中及术后阿片类药物使用量更少。使用奈福泮是影响术后疼痛评分的唯一独立因素。
与安慰剂相比,阿片类药物需求减少,手术所致疼痛及止血带疼痛均减轻。